Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 3
Submit an article Journal homepage
358
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

A phase II study to evaluate the efficacy of low-dose rasburicase (1.5mg) in adolescent and adult acute leukemia and high-grade lymphomas with tumor lysis syndrome

Swaratika Majumdara Medical Oncology, MS Ramaiah Medical College, Rajiv Gandhi University of Health Sciences, Bangalore, IndiaView further author information
,
Neha Sharmab Medical Oncology, Tata Memorial Centre, Homi Bhabha National University, Mumbai, IndiaView further author information
,
Manju Sengara Medical Oncology, MS Ramaiah Medical College, Rajiv Gandhi University of Health Sciences, Bangalore, IndiaView further author information
,
Jayashree Thorata Medical Oncology, MS Ramaiah Medical College, Rajiv Gandhi University of Health Sciences, Bangalore, IndiaView further author information
,
Lingaraj Nayaka Medical Oncology, MS Ramaiah Medical College, Rajiv Gandhi University of Health Sciences, Bangalore, IndiaView further author information
,
Avinash Bondac Medical Oncology, Homi Bhabha Cancer Hospital & Research Centre, Tata Memorial Centre, Mumbai, IndiaView further author information
,
Bhausaheb Bagala Medical Oncology, MS Ramaiah Medical College, Rajiv Gandhi University of Health Sciences, Bangalore, IndiaView further author information
,
Akhil Rajendrad Department of Medical Oncology, Cancer Institute WIA, Adyar, Chennai, IndiaView further author information
,
Amit Sethie Department of Electrical Engineering, Indian Institute of Bombay, Powai, IndiaView further author information
&
Hasmukh Jaina Medical Oncology, MS Ramaiah Medical College, Rajiv Gandhi University of Health Sciences, Bangalore, IndiaCorrespondence[email protected]
View further author information
 show all
Pages 628-638 | Received 20 Apr 2022, Accepted 04 Jan 2023, Published online: 08 Mar 2023
Supplemental material

GLAL-2022-0319-File022.docx

Download MS Word (27.1 KB)

GLAL-2022-0319-File021.docx

Download MS Word (27.1 KB)

GLAL-2022-0319-File020.docx

Download MS Word (27.3 KB)

GLAL-2022-0319-File019.docx

Download MS Word (27.2 KB)

GLAL-2022-0319-File018.docx

Download MS Word (27.3 KB)

GLAL-2022-0319-File017.docx

Download MS Word (27.3 KB)

GLAL-2022-0319-File016.docx

Download MS Word (27.3 KB)

GLAL-2022-0319-File015.docx

Download MS Word (27.2 KB)

GLAL-2022-0319-File014.docx

Download MS Word (27.3 KB)

GLAL-2022-0319-File013.docx

Download MS Word (27.1 KB)

GLAL-2022-0319-File012.docx

Download MS Word (13.6 KB)

GLAL-2022-0319-File010.docx

Download MS Word (13.9 KB)

GLAL-2022-0319-File008.docx

Download MS Word (14.5 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.